Assessment of selective auto antibodies in pregnant women with spontaneous recurrent miscarriage and non-miscarriage in al- gezira state-sudan

Nadir Abuzeid; Nassem Saeed Murshed; Esra,  Abo-Alsoad; Salah Ismail Mohammed Mohammed; Mohammed  Hussien; Ibtihag  Ibaid; A Zulfa

doi:10.52981/smlj.v10i1.2778

Nadir Abuzeid Department of Medical Microbiology, Faculty of Medical Laboratory Sciences, Omdurman Islamic University-Sudan
Nassem Saeed Murshed Department of Microbiology, Faculty of Pure and Applied Sciences, International University of Africa-Sudan.
Esra, Abo-Alsoad Department of Microbiology, Faculty of Pure and Applied Sciences, International University of Africa-Sudan.
Salah Ismail Mohammed Mohammed Department of Medical Microbiology, Faculty of Medical Laboratory Sciences, Omdurman Islamic University-Sudan
Mohammed Hussien Central Laboratory, Ministry of Science and Communication- Khartoum - Sudan
Ibtihag Ibaid Central Laboratory, Ministry of Science and Communication- Khartoum - Sudan
A Zulfa Department of pathology, Faculty of Medicine, Omdurman Islamic University-Sudan.

DOI: https://doi.org/10.52981/smlj.v10i1.2778

Keywords: Recurrent miscarriage, Antiphospholipid, Anticardiolipin, Antidouble strand DNA, Antinuclear

Abstract

Recurrent miscarriage is a critical problem in the health sector. Antiphospholipid, anticardiolipin, antinuclear and antidouble strand DNA are group of autoantibodies that bind to negatively charged phospholipids which has relation with recurrent miscarriage during the first 10 weeks of pregnancy or the birth of a dead child (still birth). The aim of this study was to detect the presence of these antibodies among pregnant women in Al-Gezira state. A case-controls study was conducted at Wad Madani Teaching Hospital Al- Gezira, Department of Obstetrics gynecological in Sudan. The cases were (90 women) 45 women with miscarriage while 45 non-miscarriage women chosen as control. Antiphospholipid, Anticardiolipin, Antinuclear and Antidouble strand DNA for IgG antibodies were analyzed in the maternal sera of all of the participants by using ELISA. Furthermore all positive and borderline results were confirmed by using immunoblot test. Out of 90 women, 45 women with miscarriage showed 2(4.4%) were positive, 2(4.4%) were negative for IgG APA 1(2.2%), 2(4.4%) were positive and borderline ACL IgG, 3(6.7%), 1(2.2%) were positive and borderline ANA IgG and negative in dsDNA while 45 women with non-miscarriage 1(2.2%) was borderline APL IgG, 1(2.2%)was borderline ANA IgG and negative in ACL and dsDNA . There were significant difference in the age, biomass index, MCV, MCHC, MPV, RDWCV, RDWSD between the two groups (P < 0.05) .The analysis of In binary logistic regression women with variable, univariate and multivariate analysis showed that preeclampsia, vaginal diseases, vaginal bleeding, menstruation cycle, RDWC, RDWSD and biomass index were significantly associated with miscarriage in both (P < 0.05). While age were significant associated with miscarriage in univariate analysis (OR= 5, 95%Cl=2-13, P value 0.001), family history (OR= 2.94, 95%Cl=2.946-948, P value.000) and antiphospholipid antibodies associated with miscarriage in multivariate miscarriage (OR= 4.4, 95%Cl=45-43.8, P value0.02). In the current study antiphospholipid, anticardiolipin and antinuclear IgG sero-positivity are associated with miscarriage.

References

1. Gleicher N, Friberg J. IgM gammopathy and the lupus anticoagulant syndrome in habitual aborters. Jama. 1985;253(22):3278-81.
2. Xu L, Chang V, Murphy A, Rock JA, Damewood M, Schlaff W, et al. Antinuclear antibodies in sera of patients with recurrent pregnancy wastage. American journal of obstetrics and gynecology. 1990;163(5):1493-7.
3. Stagnaro-Green A, Roman SH, Cobin RH, El-Harazy E, Alvarez-Marfany M, Davies TF. Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. Jama. 1990;264(11):1422-5.
4. Agarwal K, Alfirevic Z. Pregnancy loss after chorionic villus sampling and genetic amniocentesis in twin pregnancies: a systematic review. Ultrasound in Obstetrics & Gynecology. 2012;40(2):128-34.
5. Gleicher N, Weghofer A, Barad D. Female infertility due to abnormal autoimmunity: frequently overlooked and greatly under appreciated. Part II. Expert Review of Obstetrics & Gynecology. 2007;2(4):465-75.
6. Bates SM. Consultative hematology: the pregnant patient pregnancy loss. ASH Education Program Book. 2010;2010(1):166-72.
7. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology. 1999;42(7):1309-11.
8. Ford HB, Schust DJ. Recurrent pregnancy loss: etiology, diagnosis, and therapy. Reviews in obstetrics and gynecology. 2009;2(2):76.
9. Wilson W, Gharavi A, Piette J. International classification criteria for antiphospholipid syndrome: synopsis of a post-conference workshop held at the Ninth International (Tours) aPL Symposium. Lupus. 2001;10(7):457-60.
10. Bronson R. Immunology and reproductive medicine. Oxford University Press; 1995.
11. Harris E, Hughes G. Thrombosis and miscarriages-the anti-phospholipid antibody story. Isi atlas of science-immunology. 1988;1(2):155-60.
12. Lockshin MD, Druzin ML, Goei S, Qamar T, Magid MS, Jovanovic L, et al. Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. New England Journal of Medicine. 1985;313(3):152-6.
13. Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders: prevalence and clinical significance. Annals of internal medicine. 1990;112(9):682-98.
14. Mackworth-Young C, Loizou S, Walport M. Antiphospholipid antibodies and disease. QJM: An International Journal of Medicine. 1989;72(3):767-77.
15. Harris E, Boey M, Mackworth-Young C, Gharavi A, Patel B, Loizou S, et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. The Lancet. 1983;322(8361):1211-4.
16. Jivraj S. Recurrent Miscarriage and the Role of Genetic Thrombophilic Mutations. Current Women's Health Reviews. 2009;5(1):14-23.
17. Stephenson M, Kutteh W. Evaluation and management of recurrent early pregnancy loss. Clinical obstetrics and gynecology. 2007;50(1):132-45.
18. Heilmann L, Tempelhoff G-Fv, Pollow K. Antiphospholipid syndrome in obstetrics. Clinical and applied thrombosis/hemostasis. 2003;9(2):143-50.
19. Derue GJ, Englert HJ, Harris E, Gharavi A, Morgan S, Hull R, et al. Fetal loss in systemic lupus: association with anticardiolipin antibodies. Journal of Obstetrics and Gynaecology. 1985;5 (4):207-9.
20. Harris E, Asherson R, Gharavi A, Morgan S, Derue G, Hughes G. Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody. British journal of haematology. 1985;59(2):227-30.
21. Lubbe W, Palmer S, Butler WS, Liggins G. Fetal survival after prednisone suppression of
maternal lupus-anticoagulant. The Lancet. 1983;321(8338):1361-3.
22. Branch DW, Scott JR, Kochenour NK, Hershgold E. Obstetric complications associated with the lupus anticoagulant. New England Journal of Medicine. 1985;313(21):1322-6.
23. Balasch J, Reverter JC, Fábregues F, Tassies D, Rafel M, Creus M, et al. First-trimester repeated abortion is not associated with activated protein C resistance. Human reproduction (Oxford, England). 1997;12(5):1094-7.s